arrow
X

Xavier Solanich

Hospital Universitari de Bellvitge
H指数:21
被引数:7,989

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MEK inhibition achieves robust and durable responses in Erdheim–Chester disease

MEK抑制在Erdheim–Chester疾病中实现强效且持久的应答

2026-10-070
OAAI
Prevention of Tuberculosis in Patients Treated With Biological Therapies: 20 Years' Experience in a Specialized Tuberculosis Clinic in a Low-prevalence Country

生物疗法治疗患者的结核病预防:低流行国家一家专业结核病诊所20年的经验

2025-09-011
PRE
Real-world patterns of immunoglobulin replacement therapy for infection prevention in common variable immunodeficiency: a multicenter nationwide study

常见变异型免疫缺陷患者预防感染的真实世界免疫球蛋白替代治疗模式:一项多中心全国性研究

2025-07-230
OA
From Rare to Common: Genetic Insights into TLR7 Variants in a Multicentric Spanish Study on COVID-19 Severity

从罕见到常见:一项关于COVID-19严重程度的西班牙多中心研究对TLR7变异体的遗传学见解

2025-05-270
OAAI
Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry

非特异性免疫球蛋白在加泰罗尼亚三个三级医院的使用:一项医院处方用药登记的描述性分析

2024-12-160
OA
The impact of immune dysregulation on the risk of malignancy in common variable immunodeficiency: insights from a multicenter study
2024-10-160
OAAI
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Auto-abs中和I型干扰素患者的疫苗突破性低氧新型冠状病毒肺炎肺炎

2023-12-2243
OAAI
Three-day Icatibant on top of Standard Care in Patients With Coronavirus Disease-2019 Pneumonia (ICAT•COVID): A Randomized, Open-label, Phase 2, Proof-of-Concept Trial
2023-01-049
OAAI
Current clinical spectrum of common variable immunodeficiency in Spain: The multicentric nationwide GTEM-SEMI-CVID registry
2022-10-2814
OAAI
Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy

评估具有常见可变免疫缺陷表型和接受b细胞耗竭治疗的患者对SARS-CoV-2疫苗的体液和细胞免疫反应

2022-04-2917
OAAI
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
2021-09-2768
OAAI
Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths

中和I型干扰素的自身抗体存在于70岁以上未感染者的4% 中,占新型冠状病毒肺炎死亡的20%

2021-08-10407
OAAI
Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19

在患有严重新型冠状病毒肺炎的年轻和先前健康的男性中进行TLR7变异的遗传筛查

2021-07-2380
OAAI